Literature DB >> 20017148

Glucose-regulated protein 78: a new partner of p53 in trophoblast.

Serge Arnaudeau1, Patrizia Arboit, Paul Bischof, Kasuo Shin-ya, A Tomida, T Tsuruo, Olivier Irion, Marie Cohen.   

Abstract

Although wild-type p53 protein is overexpressed in first trimester trophoblast, it is inactive towards its target genes Metalloproteinase 2 and 9. This seems to be due to a complex mechanism of inactivation and stabilization of p53 relying on the formation of protein complexes involving the N-terminus of p53. To detect the proteins associated with this sequence, we incubated biotinylated p53 N-terminal peptide in cytotrophoblastic cell medium 24 h before lysis of cells. We purified the proteins retained on biotinylated peptide using a neutravidin affinity column. Proteins were then identified by peptide mass finger printing followed or not by peptide fragmentation sequencing. Among these proteins, we identified glucose-regulated protein 78 (GRP78) and verified its interaction with p53 in trophoblastic cells by immunoprecipitation and Western blot analysis. Moreover, the decreased expression of GRP78 induced by GRP78siRNA or versipelostatin decreased the formation of high molecular weight p53 complexes and p53 monomer and increased trophoblastic invasion. These results suggest that GRP78 is involved in inactivation and stabilization of p53 and in the regulation of trophoblastic invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20017148     DOI: 10.1002/pmic.200800865

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  14 in total

1.  Proteome differences in the first- and third-trimester human placentas.

Authors:  Behrouz Gharesi-Fard; Jaleh Zolghadri; Eskandar Kamali-Sarvestani
Journal:  Reprod Sci       Date:  2014-09-08       Impact factor: 3.060

Review 2.  (Dis)similarities between the Decidual and Tumor Microenvironment.

Authors:  Jelena Krstic; Alexander Deutsch; Julia Fuchs; Martin Gauster; Tina Gorsek Sparovec; Ursula Hiden; Julian Christopher Krappinger; Gerit Moser; Katrin Pansy; Marta Szmyra; Daniela Gold; Julia Feichtinger; Berthold Huppertz
Journal:  Biomedicines       Date:  2022-05-04

3.  Immunomodulatory molecules are released from the first trimester and term placenta via exosomes.

Authors:  S K Kshirsagar; S M Alam; S Jasti; H Hodes; T Nauser; M Gilliam; C Billstrand; J S Hunt; M G Petroff
Journal:  Placenta       Date:  2012-10-26       Impact factor: 3.481

Review 4.  Emerging role of nanog in tumorigenesis and cancer stem cells.

Authors:  Luis E Iv Santaliz-Ruiz; Xiujie Xie; Matthew Old; Theodoros N Teknos; Quintin Pan
Journal:  Int J Cancer       Date:  2014-01-13       Impact factor: 7.396

5.  GRP78 expression and regulation in the mouse uterus during embryo implantation.

Authors:  PengFei Lin; YaPing Jin; XiangLi Lan; YanZhou Yang; Fenglei Chen; Nan Wang; Xiao Li; YuJie Sun; AiHua Wang
Journal:  J Mol Histol       Date:  2013-11-16       Impact factor: 2.611

6.  Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.

Authors:  Meng-Ju Wu; Chia-Ing Jan; Yeou-Guang Tsay; Yau-Hua Yu; Chih-Yang Huang; Shu-Chun Lin; Chung-Ji Liu; Yu-Syuan Chen; Jeng-Fan Lo; Cheng-Chia Yu
Journal:  Mol Cancer       Date:  2010-10-27       Impact factor: 27.401

7.  GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach.

Authors:  Florence Delie; Patrick Petignat; Marie Cohen
Journal:  J Oncol       Date:  2012-03-18       Impact factor: 4.375

8.  Involvement of membrane GRP78 in trophoblastic cell fusion.

Authors:  Sarah Fradet; Sandra Pierredon; Pascale Ribaux; Manuella Epiney; Kazuo Shin Ya; Olivier Irion; Marie Cohen
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

9.  Role of prostate apoptosis response 4 in translocation of GRP78 from the endoplasmic reticulum to the cell surface of trophoblastic cells.

Authors:  Marie Cohen; Pascale Ribaux; Manuella Epiney; Olivier Irion
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

10.  Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells.

Authors:  Babak Nami; Armin Ghasemi-Dizgah; Akbar Vaseghi
Journal:  Bioimpacts       Date:  2016-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.